GAITHERSBURG, MD. – A Food and Drug Administration advisory panel unanimously supported the approval of the Cologuard DNA stool test, a first-line diagnostic test to screen for the detection of...
Routine screening for prostate cancer decreased in Ohio after the U.S. Preventive Services Task Force recommended against it, with a more immediate and pronounced decrease in the urban/academic...
Men had a 24% higher incidence of invasive cancer than women in 2010, and black men had the highest rate among men of all races/ethnicities, the Centers for Disease Control and Prevention reported...
GAITHERSBURG, MD. – The Food and Drug Administration deemed the first-of-a-kind blood test to screen for colorectal cancer safe but not effective.
At a <link...
PHOENIX, ARIZ. – Cost and quality are not always synonymous, particularly when it comes to complex surgical procedures such as esophagectomy.
A review of records on more than 6,700 patients who...
People diagnosed with melanoma were significantly more likely to have melanoma in situ and to have thinner invasive melanomas if they had a regular dermatologist, compared with those who did not have...
PHOENIX, ARIZ. – Even small pancreatic neuroendocrine tumors have the potential for malignancy and need excision or close monitoring, investigators caution.
A retrospective cohort study following...
Eligible patients who live farther away from a liver transplant center are less likely to be put on a waiting list, less likely to receive a transplant, and more likely to die within 5 years than are...
Second primary malignancies affected 10.8% of men who received I-125 brachytherapy as monotherapy for prostate cancer, researchers reported in the April issue of Clinical Oncology.
But only bladder...
For most men with localized prostate cancer who defer surgery or radiation, primary androgen deprivation therapy offers no mortality benefit, Dr. Arnold L. Potosky reported.
Dr. Potosky of...
